ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1,2,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1,4,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
2,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3,4,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
4,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
4,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
5,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Huntington's disease,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,Y
7,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
8,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
9,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
9,2,Headache,Headaches NEC,Headaches,Nerv,N
9,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
10,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
10,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
11,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
12,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
13,2,Headache,Headaches NEC,Headaches,Nerv,N
14,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
14,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
14,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
14,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
14,7,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
15,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
15,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
15,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
15,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
16,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
17,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
17,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
17,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
18,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
18,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
18,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
18,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
19,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
19,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
19,3,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
19,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
20,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
20,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
21,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
21,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
22,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
23,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
23,4,Renal atrophy,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
23,5,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
23,6,Vascular compression,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
24,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
24,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
24,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
24,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
24,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
25,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
25,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
26,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
26,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
26,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
26,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
27,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
28,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
29,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
30,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
30,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
31,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
31,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
31,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
32,1,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
33,1,Urethritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
33,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
34,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
34,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
35,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
36,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
36,2,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
36,3,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
37,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
37,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
37,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
38,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
38,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
39,1,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
40,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
41,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
41,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
41,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
41,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
42,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
43,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
43,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
43,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
44,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
45,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
45,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
46,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
49,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
49,2,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
49,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
50,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
51,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
52,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
52,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
52,3,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
52,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
52,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
52,6,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
52,7,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
52,8,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
52,9,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
52,10,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
52,11,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
52,12,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
52,13,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
52,14,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
52,15,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
52,16,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
52,17,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
52,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
53,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
53,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
53,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
53,6,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
54,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
54,3,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
55,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
55,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
55,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
55,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
55,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
55,6,Poisoning deliberate,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
55,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
55,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
55,10,Self-medication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
55,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
56,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
56,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
56,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
56,4,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
56,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
57,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
57,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
58,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
58,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
59,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
59,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
60,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
61,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
61,3,Migraine,Migraine headaches,Headaches,Nerv,N
61,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
61,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
61,6,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
61,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
62,1,Headache,Headaches NEC,Headaches,Nerv,N
